Canada · Delayed Price · Currency is CAD Cipher Pharmaceuticals Company Description
Cipher Pharmaceuticals Inc., founded in 2000 and based in Oakville, Canada, operates as a specialized pharmaceutical enterprise.
The company markets a diverse portfolio of commercial therapeutic solutions. These include Epuris (CIP-ISOTRETINOIN), formulated for severe acne; Ozenoxacin, targeting impetigo in both adult and pediatric patients; Actikerall, prescribed for palpable or moderately thick hyperkeratotic actinic keratosis; Vaniqa, a topical cream designed to mitigate unwanted facial hair growth in women; BRINAVESS, utilized for restoring sinus rhythm in adults; and AGGRASTAT, an intravenous anti-platelet medication.
Beyond its directly marketed offerings, Cipher's portfolio encompasses various licensed products, such as CIP-Isotretinoin; Lipofen (CIP-Fenofibrate), used in the management of hyperlipidemia, a lipid metabolism disorder; and Conzip/Durela (CIP-Tramadol), indicated for the relief of moderate to moderately severe pain.
Looking to the future, Cipher maintains a robust developmental pipeline, which includes Trevyent, a vasodilatory prostacyclin analogue aimed at treating pulmonary arterial hypertension; CF-101, under investigation for severe plaque psoriasis and rheumatoid arthritis; MOB-015, a topical terbinafine formulation for onychomycosis; and DTR-001, a novel cream for tattoo removal.
| Country | Canada |
| Founded | 2000 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 5 |
| CEO | Craig Mull |
Contact Details
Address: 5750 Explorer Drive Mississauga, ON ON Canada | |
| Phone | 905 602 5840 |
Stock Details
| Ticker Symbol | CPH |
| Exchange | Toronto Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | CA17253X1050 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Craig J. Mull | Interim Chief Executive Officer and Chairman of the Board |
| Bryan Jacobs | President |
| Ryan Mailling | Chief Financial Officer |
| Emilio Presti | Director of Sales and Marketing |
| Shengnan Guo | Corporate Controller |